West Family Investments Inc. Makes New Investment in HCA Healthcare, Inc. $HCA

West Family Investments Inc. bought a new position in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 613 shares of the company’s stock, valued at approximately $235,000.

A number of other institutional investors have also bought and sold shares of the business. ORG Partners LLC lifted its holdings in HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after purchasing an additional 31 shares in the last quarter. Glenview Trust co increased its holdings in HCA Healthcare by 2.3% in the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock valued at $501,000 after acquiring an additional 32 shares during the last quarter. Horizon Investments LLC boosted its holdings in shares of HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after purchasing an additional 33 shares during the last quarter. Sivia Capital Partners LLC lifted its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares in the last quarter. Finally, RWA Wealth Partners LLC grew its holdings in HCA Healthcare by 2.0% during the 1st quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company’s stock valued at $658,000 after buying an additional 37 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $512.94 on Monday. The firm has a market capitalization of $117.05 billion, a price-to-earnings ratio of 19.83, a PEG ratio of 1.38 and a beta of 1.41. The stock’s 50-day simple moving average is $452.07 and its 200-day simple moving average is $406.66. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $520.00.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the previous year, the firm earned $4.90 EPS. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is presently 11.13%.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent research reports. Morgan Stanley set a $425.00 price objective on HCA Healthcare in a research report on Monday, October 27th. TD Cowen raised their target price on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a report on Monday, October 27th. KeyCorp increased their price objective on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday. Finally, Bank of America increased their price target on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $474.53.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.